Evidence map›Paper›PMID 36133726›Full record

ArticleNanoscale advances2021

Solvophobic-controlled synthesis of smart magneto-fluorescent nanostructures for real-time inspection of metallic fractures.

Fernando Menegatti de Melo, João V Mattioni, Fernando Dias, Ying Fu, Henrique E Toma

Open access · goldAbstract read
In one paragraph

Article in Nanoscale advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 10 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Fernando Menegatti de MeloSupramolecular Nanotech Laboratory, Institute of Chemistry, University of São Paulo Avenida Professor Lineu Prestes, 748 05508000 São Paulo Brazil fernando.menegatti.melo@usp.br.ORCID https://orcid.org/0000-0003-0270-5912
João V MattioniSupramolecular Nanotech Laboratory, Institute of Chemistry, University of São Paulo Avenida Professor Lineu Prestes, 748 05508000 São Paulo Brazil fernando.menegatti.melo@usp.br.ORCID https://orcid.org/0000-0002-8725-0146
Fernando DiasMetal-Chek do Brasil Indústria e Comércio, Research & Development Department Rua das Indústrias, 135 12926674 Bragança Paulista Brazil.ORCID https://orcid.org/0000-0002-1956-8339
Ying FuSchool of Information Technology, Halmstad University SE-30118 Halmstad Sweden.ORCID https://orcid.org/0000-0002-2442-1809
Henrique E TomaSupramolecular Nanotech Laboratory, Institute of Chemistry, University of São Paulo Avenida Professor Lineu Prestes, 748 05508000 São Paulo Brazil fernando.menegatti.melo@usp.br.ORCID https://orcid.org/0000-0002-4044-391X
Halmstad University · SESanta Casa da Misericórdia de Bragança Paulista · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The production of materials that contain more than one functional constituent, the so-called multifunctional materials, is quite relevant in advanced technology. By acting as building blocks, nanoparticles can be suitably explored for generating higher-order multifunctional structures. In this regard, herein, a special clustered magneto-fluorescent superstructure has been developed for non-destructive detection of flaws and shallow subsurface discontinuities in industrial ferromagnetic materials. The strategy consists of the solvophobic-controlled assembly of organic-based maghemite cores and water-based II-VI quantum dots, in the presence of hexadecyltrimethyl-ammonium bromide, CTAB, as a compatibilizer agent. This composite exhibited a high magnetic response (

Identifiers

PMID36133726
PMCPMC9419086
OpenAlexW3159283911

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.